Showing results (261-270 of 270) with videos related to
Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 270 results.
Physical Review Letters|September 28, 2010
Landau quantization of topological surface states in Bi2Se3Peng Cheng, Canli Song, Tong Zhang, et al.Scientific Reports|August 13, 2015
Anomalous High-Energy Waterfall-Like Electronic Structure in 5 d Transition Metal Oxide Sr2IrO4 with a Strong Spin-Orbit CouplingYan Liu, Li Yu, Xiaowen Jia, et al.The Lancet. Infectious Diseases|May 22, 2023
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trialJun-Dong Wu, Jing-Xin Li, Jian Liu, et al.Scientific Reports|August 21, 2014
Evidence of topological surface state in three-dimensional Dirac semimetal Cd3As2Hemian Yi, Zhijun Wang, Chaoyu Chen, et al.Science (New York, N.Y.)|March 16, 2013
Experimental observation of the quantum anomalous Hall effect in a magnetic topological insulatorCui-Zu Chang, Jinsong Zhang, Xiao Feng, et al.Proceedings of the National Academy of Sciences of the United States of America|February 23, 2012
Robustness of topological order and formation of quantum well states in topological insulators exposed to ambient environmentChaoyu Chen, Shaolong He, Hongming Weng, et al.The Lancet. Respiratory Medicine|May 20, 2023
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre studyTao Huang, Sheng Zhang, De-Fang Dai, et al.Nature Communications|May 24, 2017
Electronic evidence of temperature-induced Lifshitz transition and topological nature in ZrTe5Yan Zhang, Chenlu Wang, Li Yu, et al.Human Vaccines & Immunotherapeutics|October 26, 2023
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trialGuang-Wei Feng, Zhong-Fang Wang, Peng He, et al.Human Vaccines & Immunotherapeutics|May 16, 2025
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trialXiao-Qiang Liu, Yang-Yang Qi, Tao Huang, et al.Pageof 27